Our recent studies supported the fundamental role of inflammation in IC/BPS, as the production of Toll-like receptor 4 (TLR4) mediated proinflammatory cytokines IL-1ß and IL-6 was significantly associated with multiple IC/BPS pain indicators [26–28]. This evidence concerns the gene TLR4 and Bartsocas-Papas syndrome 1.